AJCP / Meeting AbstrActs solid and cystic structure. The H&E slides showed tightly packed cord and trabeculae of neoplastic cell, imparting a ribbonlike appearance. There were also some areas of solid growth with nest formation, calcification, and focal ossification. The immunohistochemistry shows tumor cells were positive for CAM5.2, synaptophysin, chromogranin, and NSE, and negative for AE1/AE3, PAX8, S100, SMA, CD31, WT-1, CK7, and CK20. Conclusion: It is important to have keen knowledge of this rare entity and use appropriate immunohistochemical staining for neuroendocrine markers. Since carcinoid tumors are considered low-grade malignant tumors, correct histological diagnosis helps to avoid unnecessary aggressive treatment. The development of classic Hodgkin lymphoma (cHL) synchronously or metachronously in chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) patients is quite rare and estimated to be less than 0.4%. We are presenting a rare case of synchronous EpsteinBarr virus (EBV)-positive cHL and atypical CLL/SLL in a post-renal transplant setting. A 76-year-old man with history of bladder cancer treated with cystoprostatectomy and chemotherapy and allograft transplant on tacrolimus presented with fatigue, fever, and mediastinal lymphadenopathy on CT scan. Lymph node biopsy showed architectural effacement by monomorphous population of small lymphocytes that are CD45+, pax5+, CD19+, CD20+/-, CD5+/-, CD10-, CD11c-, CD23-, CD25+, CD103-, Bcl6-, cyclin D1-, and dim kappa light chain restriction. Ki67 proliferation index was 10%-15%. This immunophenotype is indicative of a CD5 partially positive B-cell lymphoma with features of CLL, albeit CD23 negative. Singly scattered throughout the CLL were Hodgkin Reed-Sternberg (HRS) cells that were EBV+, CD30+, CD15+, MUM1+, pax5+, and CD20-. Bone marrow biopsy showed a granulomatous infiltrate with HRS cells occupying 30%-40% of the bone marrow cellularity and accompanied by increased reticulin fibrosis. Flow cytometry of the peripheral blood and bone marrow aspirate showed minimal involvement by CLL. The diagnosis was made of a composite EBV-positive cHL and CLL. The differential diagnosis includes a polymorphic post-transplant lymphoproliferative disorder with Hodgkin-like cells. This case of composite lymphoma is unique in that it is described in the post-transplant immunosuppression setting, which is most likely a contributing factor to the EBV-positive cHL, but not the CLL. Context: Pathologists routinely assess Ki67 immunohistochemistry to grade gastrointestinal and pancreatic neuroendocrine tumors. Unfortunately, manual counts of the Ki67 index are very time consuming, and "eyeball estimation" has been criticized for being unreliable. Manual Ki67 counts performed by cytotechnologists could potentially save pathologist time and improve accuracy. Objectives: To assess the concordance between manual Ki67 index counts performed by cytotechnologists vs eyeball estimates and manual Ki67 counts by pathologists. Methods: Ki67 immunohistochemical stains were retrieved from archived gastrointestinal or pancreatic neuroendocrine tumor resections. We compared pathologist Ki67 eyeball estimates on glass slides and printed color images with manual counts by three cytotechnologists and gold standard manual Ki67 index counts by three pathologists. Results: Tumor grade agreement between pathologist image eyeball estimate and gold standard pathologist manual count was fair (K value of 0.31 [95% CI 0.03-0.60]). In nine of 20 cases (45%), the mean pathologist eyeball estimate was one grade higher than the mean pathologist manual count. There was almost perfect agreement in classifying tumor grade between the mean cytotechnologist manual count and the mean pathologist manual count (K value of 0.91 [95% CI 0.7-1.0]). In 20 cases, there was only one grade disagreement between the two methods. Eyeball estimation by pathologists required less than one minute, while manual counts by pathologists required a mean of 17 minutes per case. Conclusion: Eyeball estimation of the Ki67 index has a high rate of tumor grade misclassification compared to manual counting. Cytotechnologist manual counts are accurate and save pathologists time.
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Concurrent Classic Hodgkin Non-Hodgkin Lymphomas in a Post-Renal Transplant Setting
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